3LNK
Structure of BACE bound to SCH743813
Summary for 3LNK
Entry DOI | 10.2210/pdb3lnk/pdb |
Descriptor | Beta-secretase 1, N'-{(1S,2S)-1-(3,5-difluorobenzyl)-2-hydroxy-2-[(2R)-4-(phenylcarbonyl)piperazin-2-yl]ethyl}-5-methyl-N,N-dipropylbenzene-1,3-dicarboxamide, L(+)-TARTARIC ACID, ... (4 entities in total) |
Functional Keywords | alzheimer's, bace1, alternative splicing, aspartyl protease, disulfide bond, endoplasmic reticulum, endosome, glycoprotein, golgi apparatus, hydrolase, membrane, polymorphism, protease, transmembrane, zymogen |
Biological source | Homo sapiens (human) |
Cellular location | Membrane; Single-pass type I membrane protein: P56817 |
Total number of polymer chains | 2 |
Total formula weight | 89588.89 |
Authors | Orth, P.,Cumming, J. (deposition date: 2010-02-02, release date: 2010-04-14, Last modification date: 2023-09-06) |
Primary citation | Cumming, J.,Babu, S.,Huang, Y.,Carrol, C.,Chen, X.,Favreau, L.,Greenlee, W.,Guo, T.,Kennedy, M.,Kuvelkar, R.,Le, T.,Li, G.,McHugh, N.,Orth, P.,Ozgur, L.,Parker, E.,Saionz, K.,Stamford, A.,Strickland, C.,Tadesse, D.,Voigt, J.,Zhang, L.,Zhang, Q. Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization. Bioorg.Med.Chem.Lett., 20:2837-2842, 2010 Cited by PubMed: 20347593DOI: 10.1016/j.bmcl.2010.03.050 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.8 Å) |
Structure validation
Download full validation report